Fulton Breakefield Broenniman’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-7,123
| Closed | -$200K | – | 214 |
|
|
2026
Q1 | $200K | Sell |
7,123
-950
| -12% | -$25.3K | 0.01% | 196 |
|
|
2025
Q4 | $201K | Sell |
8,073
-488
| -6% | -$12.3K | 0.01% | 199 |
|
|
2025
Q3 | $218K | Sell |
8,561
-1,078
| -11% | -$26.6K | 0.01% | 189 |
|
|
2025
Q2 | $234K | Sell |
9,639
-700
| -7% | -$16.3K | 0.02% | 174 |
|
|
2025
Q1 | $262K | Buy |
10,339
+1,350
| +15% | +$35.3K | 0.02% | 151 |
|
|
2024
Q4 | $238K | Hold |
8,989
| – | – | 0.02% | 166 |
|
|
2024
Q3 | $260K | Sell |
8,989
-113
| -1% | -$3.3K | 0.02% | 154 |
|
|
2024
Q2 | $255K | Sell |
9,102
-3,481
| -28% | -$95.8K | 0.02% | 160 |
|
|
2024
Q1 | $349K | Buy |
12,583
+1,232
| +11% | +$34.2K | 0.03% | 135 |
|
|
2023
Q4 | $327K | Sell |
11,351
-78
| -0.7% | -$2.36K | 0.03% | 133 |
|
|
2023
Q3 | $379K | Sell |
11,429
-824
| -7% | -$29.1K | 0.03% | 124 |
|
|
2023
Q2 | $449K | Sell |
12,253
-689
| -5% | -$26.8K | 0.04% | 117 |
|
|
2023
Q1 | $528K | Sell |
12,942
-150,820
| -92% | -$6.51M | 0.05% | 110 |
|
|
2022
Q4 | $8.39M | Buy |
163,762
+411
| +0.3% | +$19.7K | 0.74% | 51 |
|
|
2022
Q3 | $7.15M | Sell |
163,351
-1,227
| -0.7% | -$59.6K | 0.67% | 54 |
|
|
2022
Q2 | $8.63M | Sell |
164,578
-4,830
| -3% | -$246K | 0.75% | 50 |
|
|
2022
Q1 | $8.77M | Buy |
169,408
+647
| +0.4% | +$33.6K | 0.77% | 48 |
|
|
2021
Q4 | $9.96M | Buy |
168,761
+1,472
| +0.9% | +$72.9K | 0.74% | 52 |
|
|
2021
Q3 | $7.2M | Sell |
167,289
-3,908
| -2% | -$173K | 0.62% | 54 |
|
|
2021
Q2 | $6.7M | Sell |
171,197
-141,285
| -45% | -$5.49M | 0.57% | 54 |
|
|
2021
Q1 | $11.3M | Buy |
312,482
+41,663
| +15% | +$1.48M | 1.05% | 45 |
|
|
2020
Q4 | $9.97M | Sell |
270,819
-60,197
| -18% | -$2.21M | 1.19% | 39 |
|
|
2020
Q3 | $11.5M | Sell |
331,016
-3,662
| -1% | -$128K | 1.3% | 35 |
|
|
2020
Q2 | $10.4M | Buy |
334,678
+3,261
| +1% | +$111K | 1.26% | 38 |
|
|
2020
Q1 | $10.3M | Sell |
331,417
-3,318
| -1% | -$113K | 1.53% | 27 |
|
|
2019
Q4 | $12.4M | Buy |
334,735
+9,361
| +3% | +$333K | 1.45% | 26 |
|
|
2019
Q3 | $11.1M | Buy |
325,374
+8,026
| +3% | +$292K | 1.41% | 28 |
|
|
2019
Q2 | $13M | Buy |
317,348
+2,389
| +0.8% | +$94.9K | 2.06% | 18 |
|
|
2019
Q1 | $12.7M | Buy |
314,959
+706
| +0.2% | +$28.3K | 2.06% | 16 |
|
|
2018
Q4 | $13M | Buy |
314,253
+927
| +0.3% | +$38.5K | 2.3% | 7 |
|
|
2018
Q3 | $13.1M | Sell |
313,326
-2,304
| -0.7% | -$88.7K | 2.04% | 13 |
|
|
2018
Q2 | $10.9M | Buy |
315,630
+114
| +0% | +$3.9K | 1.74% | 19 |
|
|
2018
Q1 | $10.6M | Sell |
315,516
-5,225
| -2% | -$180K | 1.84% | 16 |
|
|
2017
Q4 | $11M | Buy |
320,741
+870
| +0.3% | +$29.7K | 1.85% | 17 |
|
|
2017
Q3 | $10.8M | Sell |
319,871
-9,129
| -3% | -$293K | 1.89% | 11 |
|
|
2017
Q2 | $10.5M | Buy |
329,000
+16
| +0% | +$505 | 1.87% | 13 |
|
|
2017
Q1 | $10.7M | Buy |
328,984
+2,639
| +0.8% | +$83.2K | 1.98% | 11 |
|
|
2016
Q4 | $10.1M | Buy |
326,345
+2,674
| +0.8% | +$81.6K | 1.99% | 12 |
|
|
2016
Q3 | $10.4M | Buy |
323,671
+695
| +0.2% | +$23.2K | 2.11% | 6 |
|
|
2016
Q2 | $10.8M | Buy |
322,976
+1,823
| +0.6% | +$58.2K | 2.2% | 5 |
|
|
2016
Q1 | $9.03M | Sell |
321,153
-655
| -0.2% | -$18.7K | 1.98% | 11 |
|
|
2015
Q4 | $9.86M | Buy |
321,808
+23,266
| +8% | +$732K | 2.18% | 5 |
|
|
2015
Q3 | $8.9M | Buy |
298,542
+2,625
| +0.9% | +$84.2K | 2.1% | 4 |
|
|
2015
Q2 | $9.41M | Buy |
295,917
+150
| +0.1% | +$4.89K | 2.06% | 2 |
|
|
2015
Q1 | $9.76M | Buy |
295,767
+4,785
| +2% | +$152K | 2.17% | 2 |
|
|
2014
Q4 | $8.6M | Buy |
290,982
+5,042
| +2% | +$145K | 1.88% | 9 |
|
|
2014
Q3 | $8.02M | Buy |
285,940
+2,596
| +0.9% | +$72.9K | 1.88% | 7 |
|
|
2014
Q2 | $7.98M | Sell |
283,344
-1,076
| -0.4% | -$30.7K | 1.93% | 5 |
|
|
2014
Q1 | $8.67M | Buy |
284,420
+6,622
| +2% | +$197K | 2.23% | 1 |
|
|
2013
Q4 | $8.07M | Sell |
277,798
-1,494
| -0.5% | -$43.5K | 2.13% | 3 |
|
|
2013
Q3 | $7.61M | Buy |
279,292
+10,838
| +4% | +$295K | 2.05% | 1 |
|
|
2013
Q2 | $7.13M | Buy |
+268,454
| New | +$7.42M | 2.09% | 1 |
|
Other funds holding PFE
Fulton Breakefield Broenniman's PFE Position: Q2 2026 in Review
Fulton Breakefield Broenniman sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,123 shares — an estimated $200K sold.
Fulton Breakefield Broenniman first reported a position in PFE in Q2 2013 and held it in 52 quarters. The position peaked at $13.1M in Q3 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Fulton Breakefield Broenniman reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Fulton Breakefield Broenniman sold 7,123 Pfizer shares in Q2 2026, an estimated $200K.
- Fulton Breakefield Broenniman first reported a position in Pfizer in Q2 2013 and held it in 52 quarters.
- Fulton Breakefield Broenniman's Pfizer position peaked at $13.1M in Q3 2018.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.